Literature DB >> 2425837

Mapping epitope characteristics on carcinoembryonic antigen.

P J Harwood, D W Britton, P J Southall, G M Boxer, G Rawlins, G T Rogers.   

Abstract

A method of epitope analysis is described in which the binding of one monoclonal antibody (MAb) to radiolabeled carcinoembryonic antigen (CEA) competes with the subsequent binding of an immobilised second MAb. From the degree of blocking obtained, we have identified both structurally related and independent epitopes on CEA. Using this technique to study fifteen MAbs, we have been able to recognise at least 6 unrelated epitopes of the CEA glycoprotein. Further characterisation of these epitopes was accomplished by means of immunohistochemistry. Of the fifteen MAbs, 6 were specific for CEA and reacted with at least 3 unrelated regions of the glycoprotein. Of the remaining 9 MAbs, 2 cross-reacted with erythrocytes, 5 with components of liver and 7 with polymorphonuclear neutrophils. Cross-reactions with liver were varied showing differential antibody specificity for bile canaliculi, Kupffer cells and bile duct epithelium. A high degree of correlation between epitope relatedness and immunohistochemical specificity was found. Two CEA-specific and 4 cross-reactive MAbs were also shown to react with ion-sensitive sites on the CEA glycoprotein.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425837      PMCID: PMC2001645          DOI: 10.1038/bjc.1986.154

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Identification of an antigen from normal human tissue that crossreacts with the carcinoembryonic antigen.

Authors:  S von Kleist; G Chavanel; P Burtin
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

2.  Carcinoembryonic antigen (CEA) and related antigens in blood cells and hematopoietic tissues.

Authors:  M Bordes; S Knobel; F Martin
Journal:  Eur J Cancer       Date:  1975-11       Impact factor: 9.162

3.  Tissue preparation for the demonstration of surface antigen by immunoperoxidase techniques.

Authors:  M A Judd; K J Britten
Journal:  Histochem J       Date:  1982-09

Review 4.  Biochemical monitoring of cancer. A review.

Authors:  A M Neville; E H Cooper
Journal:  Ann Clin Biochem       Date:  1976-01       Impact factor: 2.057

5.  Carcinoembryonic antigen-like substances of human bile. Isolation and partial characterization.

Authors:  T Svenberg
Journal:  Int J Cancer       Date:  1976-05-15       Impact factor: 7.396

6.  Binding studies on two different monoclonal antibodies raised against CEA.

Authors:  G T Rogers; G A Rawlins; A Kardana; A R Gibbons
Journal:  Eur J Cancer Clin Oncol       Date:  1983-05

7.  Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.

Authors:  F J Primus; W J Kuhns; D M Goldenberg
Journal:  Cancer Res       Date:  1983-02       Impact factor: 12.701

8.  Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

Authors:  C M Haskell; F Buchegger; M Schreyer; S Carrel; J P Mach
Journal:  Cancer Res       Date:  1983-08       Impact factor: 12.701

9.  Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril.

Authors:  P J Fraker; J C Speck
Journal:  Biochem Biophys Res Commun       Date:  1978-02-28       Impact factor: 3.575

10.  DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES.

Authors:  P GOLD; S O FREEDMAN
Journal:  J Exp Med       Date:  1965-03-01       Impact factor: 14.307

View more
  14 in total

1.  Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft.

Authors:  R B Pedley; J Boden; P A Keep; P J Harwood; A J Green; G T Rogers
Journal:  Eur J Nucl Med       Date:  1987

2.  Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma.

Authors:  G T Rogers; R B Pedley; J Boden; P J Harwood; K D Bagshawe
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Antitumor effects of an antibody-carboxypeptidase G2 conjugate in combination with a benzoic acid mustard prodrug.

Authors:  D C Blakey; B E Valcaccia; S East; A F Wright; F T Boyle; C J Springer; P J Burke; R G Melton; K D Bagshawe
Journal:  Cell Biophys       Date:  1993 Jan-Jun

4.  Mapping of monoclonal antibody-defined epitopes associated with carcinoembryonic antigen, CEA.

Authors:  M R Price; S Edwards; E Jacobs; I Z Pawluczyk; V S Byers; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

5.  Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice.

Authors:  P Antoniw; C J Springer; K D Bagshawe; F Searle; R G Melton; G T Rogers; P J Burke; R F Sherwood
Journal:  Br J Cancer       Date:  1990-12       Impact factor: 7.640

6.  Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.

Authors:  G M Boxer; R H Begent; A M Kelly; P J Southall; S B Blair; N A Theodorou; P M Dawson; J A Ledermann
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

7.  The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA.

Authors:  Li Peng; Michael D Oberst; Jiaqi Huang; Philip Brohawn; Chris Morehouse; Kristen Lekstrom; Patrick A Baeuerle; Herren Wu; Yihong Yao; Steven R Coats; William Dall'Acqua; Melissa Damschroder; Scott A Hammond
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

8.  Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A.

Authors:  J A Ledermann; R H Begent; K D Bagshawe; S J Riggs; F Searle; M G Glaser; A J Green; R G Dale
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

9.  Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer.

Authors:  S D Blair; N A Theodorou; R H Begent; P M Dawson; M Salmon; S Riggs; A Kelly; G Boxer; P Southall; P Gregory
Journal:  Br J Cancer       Date:  1990-06       Impact factor: 7.640

10.  Localisation of monoclonal antibodies reacting with different epitopes on carcinoembryonic antigen (CEA)--implications for targeted therapy.

Authors:  G M Boxer; A M Abassi; R B Pedley; R H Begent
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.